Margins vs Outcomes in Post Acute Care

Post acute leaders face a difficult financial equation: deliver dependable care while managing labor costs, reimbursement pressure, and increasingly complex patient needs. When margins tighten, reducing visits, staffing, or education can seem like the fastest response. Yet a lower operating expense does not necessarily mean a more efficient organization. Sometimes it means that costs—and clinical risks—have moved elsewhere.

The leadership challenge is to understand which expenditures create patient value, which prevent avoidable costs, and which represent waste. Sustainable performance requires examining margins and outcomes together.

What the evidence tells us

Medicare’s original Home Health Value-Based Purchasing Model offers evidence that quality improvement and spending reductions can coexist. CMS reports that the model produced an average 4.6 percent improvement in agencies’ total performance scores and average annual Medicare savings of $141 million. Its evaluation also identified reductions in unplanned hospitalizations and skilled nursing facility stays. These are model-level findings, not a guarantee that every participating agency improved its operating margin.

That distinction matters. Savings to Medicare do not automatically become savings to a provider. An agency may invest in additional clinical oversight while the financial benefit of an avoided hospitalization accrues primarily to the payer. Leaders must understand their reimbursement arrangements before assuming that better outcomes will immediately improve profitability.

Payment policy nevertheless creates a more direct connection in some settings. Under expanded home health value-based purchasing, quality performance can produce Medicare fee-for-service payment adjustments ranging from negative 5 percent to positive 5 percent, with performance affecting a later payment year.

Quality metrics and outcomes are different

A completed assessment is evidence that a process occurred. It does not establish that a patient recovered function, understood a medication change, or received relief from distress.

Post acute organizations need both process measures and outcomes. Timely medication reconciliation can help identify discrepancies; medication-related harm tells leaders whether patients are safer. Documented caregiver education indicates teaching occurred; caregiver understanding helps establish whether that teaching worked.

The appropriate outcome also depends on the setting. In rehabilitation, meaningful improvement may include greater independence with transfers. In home health, it may include safely managing care at home. In hospice, it may mean relief of symptoms and care consistent with the patient’s wishes. A single utilization target cannot adequately describe success across these populations.

The hidden cost of reducing capacity

Consider a home health agency that reduces clinical coordination time. Payroll expense may fall, but clinicians may spend more time locating orders, resolving incomplete referrals, or repeating calls. Patients may experience delays while staff work around an unreliable process.

This is a plausible operational pathway, not proof that every staffing reduction causes harm. Leaders should test it using their own data: delayed starts, missed visits, overtime, medication discrepancies, and patient experience.

The same discipline applies to technology. A new platform creates value only when it improves decisions or removes unnecessary work. Digitizing a fragmented workflow can preserve its inefficiencies while adding another expense.

Read the financial and clinical story together

A useful executive review connects three questions: What did care cost? How reliably was it delivered? What changed for the patient?

For example, review cost per episode alongside functional improvement, hospitalization, and patient experience. Examine staffing expense alongside missed care, overtime, and turnover. Interpret results by patient complexity, payer, geography, and service line before concluding that one team is more efficient than another.

A lower average cost may reflect a less complex patient population. A higher cost may reflect appropriate care for patients with greater needs. Neither conclusion should be assumed without investigation.

Protect access while improving performance

Outcome targets can create unintended incentives. An organization focused narrowly on hospitalization rates could become reluctant to accept complex patients or hesitate to escalate care.

Appropriate emergency treatment should never be delayed to protect a metric. Leaders should distinguish potentially avoidable utilization from clinically necessary care and monitor whether access changes as performance expectations increase.

This broader approach is increasingly relevant. CMS’s skilled nursing facility value-based purchasing program assesses eight quality measures for fiscal year 2027, expanding beyond its earlier emphasis on a single readmission measure.

Start with one costly failure

Rather than launching multiple disconnected initiatives, select a recurring problem: incomplete transitions, delayed symptom response, or preventable medication discrepancies. Establish a baseline, identify the process failure, and test a focused change.

Measure implementation cost and patient benefit together. Expand the change only when results support it.

Healthy margins preserve an organization’s ability to serve. Meaningful outcomes establish why that service matters. Post acute leadership becomes more effective when both are treated as responsibilities of the same operating system.

The Health Outcomes Institute helps healthcare organizations connect clinical and cost analysis with practical quality improvement.